BioTechnology: An Indian Journal
ISSN (PRINT): 0974-7435

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Acute Myeloid Leukemia Innovations

AML advances quickly, with myeloid cells meddling with the creation of ordinary white platelets, red platelets and platelets. Indications incorporate exhaustion, fever, intermittent diseases and wounding of the body without any problem. Intense myeloid leukemia (AML) is brought about by a DNA change in the foundational microorganisms in your bone marrow that produce red platelets, platelets and disease battling white platelets. The transformation makes the undifferentiated organisms produce a lot more white platelets than are required. Most signs and indications of AML are brought about by the supplanting of typical platelets with leukemic cells. AML is the most widely recognized kind of intense leukemia. It happens when the bone marrow starts to make impacts, cells that have not yet totally developed. These impacts regularly form into white platelets. In any case, in AML, these cells don't create and can't avoid infections. AML is the most well-known kind of intense leukemia. It happens when the bone marrow starts to make impacts, cells that have not yet totally developed.  

High Impact List of Articles

Relevant Topics in General Science

Awards Nomination

Table of Contents

Google Scholar citation report
Citations : 875

BioTechnology: An Indian Journal received 875 citations as per Google Scholar report

Citation image

Indexed In

  • CASS
  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Secret Search Engine Labs
  • Euro Pub
  • ICMJE

View More

Recommended Conferences

27th European Biotechnology Congress

Rome, Italy

For Authors

For Librarians

Flyer

Open Access Journals